Jiro Hitomi
- Molecular Biology top 10%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Immunology top 10%
- Cell Biology top 5%
- Co-authors
- Sumio IsogaiKarina YanivBrant M. WeinsteinDaniel CastranovaLouis DyeTatsuo UshikiMasatsugu ShigenoSusumu Yamamoto
- Topics
- S100 Proteins and Annexins (8 papers)Force Microscopy Techniques and Applications (6 papers)Cerebrovascular and Carotid Artery Diseases (6 papers)
- Cited by
- OncologyCell BiologyImmunology
- Partner nations
- JapanUnited StatesSpain
In The Last Decade
Jiro Hitomi
76 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 127
- Molecular Biology 830
- Oncology 477
- Pulmonary and Respiratory Medicine 279
- Immunology 276
- Cell Biology 268
Countries citing papers authored by Jiro Hitomi
This map shows the geographic impact of Jiro Hitomi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiro Hitomi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiro Hitomi more than expected).
Fields of papers citing papers by Jiro Hitomi
This network shows the impact of papers produced by Jiro Hitomi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiro Hitomi. The network helps show where Jiro Hitomi may publish in the future.
Co-authorship network of co-authors of Jiro Hitomi
This figure shows the co-authorship network connecting the top 25 collaborators of Jiro Hitomi. A scholar is included among the top collaborators of Jiro Hitomi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiro Hitomi. Jiro Hitomi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 2 | |
| 3 | 10 | |
| 4 | 8 | |
| 5 | 50 | |
| 6 | 7 | |
| 7 | 28 | |
| 8 | 1 | |
| 9 | 5 | |
| 10 | 13 | |
| 11 | 17 | |
| 12 | 31 | |
| 13 | 1 | |
| 14 | 11 | |
| 15 | 42 | |
| 16 | Archival Analysis of p53 Protein Overexpression and Genetic Mutation in Esophageal Squamous Cell Carcinoma | 5 |
| 17 | 17 | |
| 18 | 70 | |
| 19 | 5 | |
| 20 | The presence of c-erbB-2 gene product-related protein in culture medium conditioned by breast cancer cell line SK-BR-3. | 25 |
About Jiro Hitomi
Jiro Hitomi is a scholar working on Cell Biology, Structural Biology and Cancer Research, having authored 78 papers that have together received 2.0k indexed citations. Recurring topics across this work include S100 Proteins and Annexins (8 papers), Force Microscopy Techniques and Applications (6 papers) and Cerebrovascular and Carotid Artery Diseases (6 papers). The work is most often cited by research in Oncology (477 citations), Cell Biology (268 citations) and Immunology (276 citations). Jiro Hitomi has collaborated with scholars based in Japan, United States and Spain. Frequent co-authors include Sumio Isogai, Karina Yaniv, Brant M. Weinstein, Daniel Castranova, Louis Dye, Tatsuo Ushiki, Masatsugu Shigeno, Susumu Yamamoto, Jun Sakata and Hisami Watanabe. Their work appears in journals such as Nature Medicine, Nature Communications and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.